Safety and Tolerability of Losartan to Treat Recessive Dystrophic Epidermolysis Bullosa in Children (REFLECT): an Open-Label, Single-Arm, Phase 1/2 Trial
ECLINICALMEDICINE(2024)
Key words
Genetic blistering disorder,Dystrophic epidermolysis bullosa,COL7A1,Symptom relief therapy,Skin fragility
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined